BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu ZP, Zhang QY, Chen WY, Huang YY, Zhang YQ, Gong Y, Jiang Y, Bai J, Chen ZY, Dai HS. Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma. J Gastrointest Surg 2022. [PMID: 34973138 DOI: 10.1007/s11605-021-05211-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Cheng Z, Dai H, Zhong S, Zhao D, Gong Y, Zuo J, Che X, Chen W, Wang Z, Yu T, Cheng J, Liu X, Bai J, Jiang Y, Zhang Y, Lau WY, Deng S, Chen Z. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: A multicentre propensity score matching study. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1059581] [Reference Citation Analysis]
2 Zhang D, Qi F, Sun W, Zhao G, Wang D, Zhou S, Liu Z, Lu Z. Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort. Eur J Med Res 2022;27:214. [DOI: 10.1186/s40001-022-00851-4] [Reference Citation Analysis]
3 Liu Z, Chen W, Wang Z, Liu X, Fan H, Xu L, Pan Y, Zhong S, Xie D, Bai J, Jiang Y, Zhang Y, Dai H, Chen Z. Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study. Front Oncol 2022;12:849053. [DOI: 10.3389/fonc.2022.849053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu ZP, Chen WY, Zhang YQ, Jiang Y, Bai J, Pan Y, Zhong SY, Zhong YP, Chen ZY, Dai HS. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma. World J Gastroenterol 2022; 28(9): 948-960 [DOI: 10.3748/wjg.v28.i9.948] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]